US · Healthcare · Health Information Services
EPS came in at 1.07 against a street estimate of 0.94 — a beat of 13.8%.
Analysts rate HealthEquity Inc a strong buy (13 buy, 1 hold, 0 sell out of 14) with an average price target of $118.53.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.56% |
| Wasatch Advisors LP | 9.50% |
| Vanguard Portfolio Management, LLC | 4.97% |
| Vanguard Capital Management, LLC | 4.56% |
| State Street Corp | 3.70% |
| Morgan Stanley - Brokerage Accounts | 2.97% |
| Geode Capital Management, LLC | 2.70% |
| AQR Capital Management LLC | 2.50% |
| Document | Date |
|---|---|
| Shareholder vote results · Q2 2026 | 2026-06-26 |
| Quarterly report · Q2 2026 | 2026-05-28 |
| Results announced · Q2 2026 | 2026-05-28 |
| Proxy statement · Q1 2026 | 2026-05-13 |
| Board / officer change · Q2 2026 | 2026-05-08 |
| Board / officer change · Q2 2026 | 2026-04-06 |
| Annual report FY2026 | 2026-03-17 |
| Quarterly report · Q4 2025 | 2025-12-03 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for HealthEquity Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.